Acurx Pharmaceuticals (ACXP)
(Real Time Quote from BATS)
$1.84 USD
0.00 (0.00%)
Updated Nov 12, 2024 02:52 PM ET
3-Hold of 5 3
D Value C Growth C Momentum D VGM
View All Zacks #1 Ranked StocksAcurx Pharmaceuticals, Inc. (ACXP) Price Targets
| Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
|---|---|---|---|
| $12.00 | $14.00 | $10.00 | 552.17% |
Price Target
Based on short-term price targets offered by three analysts, the average price target for Acurx Pharmaceuticals, Inc. comes to $12.00. The forecasts range from a low of $10.00 to a high of $14.00. The average price target represents an increase of 552.17% from the last closing price of $1.84.
Analyst Price Targets (3 )
Broker Rating
Acurx Pharmaceuticals, Inc. currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by three brokerage firms. The current ABR compares to an ABR of 1.00 a month ago based on two recommendations.
Of the three recommendations deriving the current ABR, three are Strong Buy, representing 100% of all recommendations. A month ago, Strong Buy represented 100%.
Broker Rating Breakdown
Brokerage Recommendations
| Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| ABR | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
| Date | Brokerage Firm | Analyst | Previous | Current |
|---|---|---|---|---|
| 9/11/2024 | Alliance Global Partners | James Molloy | Not Available | Strong Buy |
| 8/12/2024 | H.C. Wainwright & Co. | Ed Arce | Strong Buy | Strong Buy |
| 5/16/2024 | Maxim Group | Jason Mccarthy | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
| Current ABR | 1.00 |
| ABR (Last week) | 1.00 |
| # of Recs in ABR | 3 |
| Average Target Price | $12.00 |
| LT Growth Rate | NA |
| Industry | Medical - Biomedical and Genetics |
| Industry Rank by ABR | 73 of 252 |
| Current Quarter EPS Est: | -0.23 |
ACXP FAQs
Acurx Pharmaceuticals, Inc. (ACXP) currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 3 brokerage firms.
The average price target for Acurx Pharmaceuticals, Inc. (ACXP) is $12.00. The current on short-term price targets is based on 1 reports.
The forecasts for Acurx Pharmaceuticals, Inc. (ACXP) range from a low of $10 to a high of $14. The average price target represents a increase of $552.17 from the last closing price of $1.84.
The current UPSIDE for Acurx Pharmaceuticals, Inc. (ACXP) is 552.17%
Based on short-term price targets offered by three analysts, the average price target for Acurx Pharmaceuticals, Inc. comes to $12.00. The forecasts range from a low of $10.00 to a high of $14.00. The average price target represents an increase of 552.17% from the last closing price of $1.84.